BIIB
BIIB
NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$197.95
+4.50 (+2.33%)
As of May 11, 9:36 PM ET ·
Analyst Consensus
Buy
43
Analysts
Very High
Coverage
Buy 24 56%
Hold 18 42%
Sell 1 2%
Price Target
Analyst Price Target -53.8% upside
Low Target $57.23
Average Target $91.45
High Target $114.90
Current Price $197.95
Current
$197.95
Target
$91.45
$57.23 $91.45 avg $114.90
Scenario Analysis
Bear Case
$57.23
-71.1%
Low target
Base Case
$91.45
-53.8%
Avg target
Bull Case
$114.90
+-42.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$202.41
-2.2% from high
52-Week Low
$115.25
+71.8% from low
50-Day SMA
$179.51
+10.3% vs SMA
200-Day SMA
$150.33
+31.7% vs SMA
RSI (14)
64.3
Neutral
Target vs 52W High
$91.45
-54.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.0%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.1%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +171.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.1%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -20.8%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +38.0%